-transparent.png){kind=logo}
The acyclic nucleotide analogue (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA] is a potent and selective inhibitor of African swine fever virus (ASFV) replication. Using the DNA-DNA hybridization technique with plasmid pRPEL-2 as probe, we have shown that (S)-HPMPA exerts a specific, dose-dependent, inhibitory effect on viral DNA synthesis. Also, (S)-HPMPA inhibits the production of late viral proteins, especially IP-73, in ASFV-infected MS and Vero cells. When evaluated under the same experimental conditions, phosphonoacetic acid (PAA) also caused an inhibition of viral DNA and late viral protein synthesis but only so at a concentration which was 10- to 20-fold higher than that required for (S)-HPMPA.
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
October 1987,
Molecular pharmacology,
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
January 1987,
Nucleic acids symposium series,
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
May 1998,
Antimicrobial agents and chemotherapy,
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
September 1994,
Molecular and biochemical parasitology,
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
November 1990,
Virology,
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
April 1987,
European journal of clinical microbiology,
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
April 1996,
Tropical medicine & international health : TM & IH,
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
February 1998,
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
February 1987,
Antimicrobial agents and chemotherapy,
O Arzuza, and
D García-Villalón, and
E Tabarés, and
C Gil-Fernández, and
E De Clercq
November 2007,
Antimicrobial agents and chemotherapy,
